Two biotechs have carved out a regulatory pathway for what could become the first FDA-approved preventative peanut allergy therapies.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Kingwell, K. Food allergy drugs step up to Phase III. Nat Rev Drug Discov 15, 149–150 (2016). https://doi.org/10.1038/nrd.2016.24
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2016.24
- Springer Nature Limited
This article is cited by
-
Peanut allergy potential
Nature Reviews Drug Discovery (2019)